RANA PRATHAP MERCY PATHROSE: Open Payments
NPI 1992188395 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 13 payments from 8 companies in 2025. Trend: 2023 $13 · 2024 $58 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: FANAPT, Jornay PM, Auvelity, UZEDY, INGREZZA, VRAYLAR, TRINTELLIX, SPRAVATO.
Industry payments across IN — which companies pay providers there.
